Apex Biotechnology Corp. (1733)
TWSE
Closed
Oct 5, 2026
Day's Range
30.1552 wk Range
28.00Overview - 1733 - Apex Biotechnology Corp.
Key Statistics
Valuation
Enterprise Value
2.30B
P/E (Trailing)
‪15.76‬
P/E (Forward)
‪15.60‬
PEG Ratio
‪0.57‬
Price / Sales (TTM)
‪1.59‬
Price / Book
‪1.60‬
EV / EBITDA
‪10.42‬
Profitability
Gross Margin
‪33.63%‬
Profit Margin
‪10.19%‬
Operating Margin
‪9.48%‬
Return on Assets
‪4.36%‬
Return on Equity
‪10.43%‬
Ownership
Shares Outstanding
99.95M
Float
60.19M
Held by Insiders
‪37.67%‬
Held by Institutions
‪1.27%‬
Price stats
Beta
‪0.26‬
50-Day Avg
‪31.18‬
200-Day Avg
‪30.14‬
Dividends
Payout Ratio
‪68.78%‬
Frequency
Annual
Analyst Consensus
1 analysts
Market Cap - 1733 - Apex Biotechnology Corp.
Peers - 1733 - Apex Biotechnology Corp.
Peer Comparison
Compared with companies in Medical Devices listed on TWSE.
Profile Summary - 1733 - Apex Biotechnology Corp.
About
Apex Biotechnology Corp. is a leading player in the life sciences sector, primarily engaged in the research, development, and commercialization of innovative biotechnological solutions. The company focuses on creating advanced therapeutic tools and diagnostic products that address a wide array of health challenges,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
